Index
- Acute Treatment of Migraine in Pediatrics: Guidelines and Recommendations
- Preventative Treatment of Migraine in Pediatrics
- Key Studies
- Childhood and Adolescent Migraine Prevention Study (CHAMP)
- OnabotulinumtoxinA for Chronic Migraine Prophylaxis in Pediatrics
- Nerve Blocks for Pediatric Refractory Migraine
- Devices for Acute and Preventative Treatment of Migraine in Pediatrics
- Anti-Calcitonin Gene-Related Peptide (CGRP) Treatment Recommendations
- Ongoing Pediatric Trials for CGRP Antagonists and Related Treatments (Szperka CL et al., 2018)
- CGRP Receptor Antagonists
- References
Acute Treatment of Migraine in Pediatrics: Guidelines and Recommendations
Guidelines Overview
- Published By: American Headache Society and American Academy of Neurology (Oskui M et al., 2019A; 2019B)
- Year: 2019
- Focus Areas:
- Prompt treatment
- Migraine characteristics and associated symptoms
- Medication formulation
- Incorporation of healthy lifestyle habits
Importance of Acute Treatment
- Risks of Ineffective Treatment:
- Medication overuse headache
- Progression to chronic migraine
Medication and Treatment Options
- Correct headache diagnosis
- Diagnostic testing for secondary headache disorders
- Assessment of premonitory/aura symptoms, headache features, associated symptoms, and overall disability
- Goal: Quick-acting, effective therapy with minimal side effects
Counseling and Early Intervention
- Triptans:
- Most effective for pain relief
- Less effect on associated nausea and vomiting
Considerations for Triptan Selection
- Limited clinical trials for migraine-associated nausea
- Demonstrated safety in pediatric gastroenteritis
- Recommended for significant nausea or vomiting
Patient and Family Education
- Over-the-Counter Medications:
- Acetaminophen, ibuprofen, naproxen
- Weight-based doses
Login to Read More
Login
- Editor(s): CNKE contributors
